The offering provides near-term cash to address a Nasdaq equity deficiency, but the dilution is material for a $5M market cap company. Monitor for Nasdaq's formal compliance determination and the next periodic report for evidence of sustained compliance. The stock may face continued pressure from the overhang of potential delisting and further dilution risk.
Price Chart
Executive Summary
Jupiter Neurosciences completed a registered direct offering of 307,692 shares at $6.50/share for ~$2.0M in gross proceeds. The company states this brings stockholders' equity above the $2.5M Nasdaq minimum, but formal compliance determination is pending. This is a dilutive capital raise by a micro-cap company facing potential delisting, with no operational catalyst disclosed.
Key Facts
- Issued and sold 307,692 shares of common stock at $6.50 per share in a registered direct offering.
- Aggregate gross proceeds of approximately $2.0 million before fees and expenses.
- Company believes stockholders' equity now exceeds the $2.5 million minimum for continued Nasdaq listing.
- Nasdaq formal determination of compliance is pending; delisting risk remains if compliance is not evidenced at next periodic report.
- Offering closed on August 24, 2026, the same day as the filing.
Financial Impact
Gross proceeds of ~$2.0M from sale of 307,692 shares at $6.50/share; dilution of approximately 307,692 new shares.
Risk Factors
- Nasdaq may not formally confirm compliance, leading to delisting proceedings.
- Further dilution may be needed if cash runway is insufficient.
- Micro-cap biotech with no disclosed pipeline catalysts or revenue to support valuation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-039886 |
| Document: 0001493152-26-039886-index.html | 0001493152-26-039886 |
| Document: 0001493152-26-039886.txt | 0001493152-26-039886 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13G/A | $2.88 | awaiting T+5 | — | $2.64 (−8.33%) |
Sep 24, 2026 4w ago | S-3 | $2.67 $2.55 | ▲ +4.49% | ▲ +4.27% | $2.64 (+1.12%) |
Sep 22, 2026 5w ago | SC 13G | $2.98 $2.58 | ▼ −13.42% | ▼ −12.24% | $2.64 (−11.41%) |
Aug 28, 2026 8w ago | 8-K | $3.54 $3.08 | ▲ +12.99% | ▲ +12.85% | $2.64 (+25.42%) |
Aug 27, 2026 8w ago | 8-K | $4.89 $3.26 | ▲ +33.33% | ▲ +33.60% | $2.64 (+46.01%) |
Aug 24, 2026 9w ago | 8-K | $5.17 $3.35 | ▲ +35.20% | ▲ +34.66% | $2.64 (+48.94%) |
Aug 24, 2026 9w ago | 8-K | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.64 (+53.36%) |
Aug 24, 2026 9w ago | 424B5 | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.64 (+53.36%) |
Jul 27, 2026 13w ago | 8-K | $0.1135 $0.1000 | ▲ +11.89% | ▲ +14.41% | $2.64 (−2225.99%) |
Jul 21, 2026 14w ago | Press Release | $0.1697 $0.1097 | ▼ −35.36% | ▼ −34.36% | $2.64 (+1455.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers